299 related articles for article (PubMed ID: 15731475)
1. Is heparin treatment the optimal management for cerebral venous thrombosis? Effect of abciximab, recombinant tissue plasminogen activator, and enoxaparin in experimentally induced superior sagittal sinus thrombosis.
Röttger C; Madlener K; Heil M; Gerriets T; Walberer M; Wessels T; Bachmann G; Kaps M; Stolz E
Stroke; 2005 Apr; 36(4):841-6. PubMed ID: 15731475
[TBL] [Abstract][Full Text] [Related]
2. Histopathological effects of different therapy strategies in experimental sinus thrombosis.
Stolz E; Fett A; Wessels C
Neurol Sci; 2014 Aug; 35(8):1281-5. PubMed ID: 24627228
[TBL] [Abstract][Full Text] [Related]
3. A new model of reversible sinus sagittalis superior thrombosis in the rat: magnetic resonance imaging changes.
Röttger C; Bachmann G; Gerriets T; Kaps M; Kuchelmeister K; Schachenmayr W; Walberer M; Wessels T; Stolz E
Neurosurgery; 2005 Sep; 57(3):573-80; discussion 573-80. PubMed ID: 16145538
[TBL] [Abstract][Full Text] [Related]
4. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
5. Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTA/stenting improves clinical outcome in acute vertebrobasilar occlusion: combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (FAST): results of a multicenter study.
Eckert B; Koch C; Thomalla G; Kucinski T; Grzyska U; Roether J; Alfke K; Jansen O; Zeumer H
Stroke; 2005 Jun; 36(6):1160-5. PubMed ID: 15890988
[TBL] [Abstract][Full Text] [Related]
6. Endovascular thrombolysis for pediatric cerebral sinus venous thrombosis with tissue plasminogen activator and abciximab.
Khan IS; Ladner TR; Satti KF; Ehtesham M; Jordan LC; Singer RJ
J Neurosurg Pediatr; 2014 Jan; 13(1):68-71. PubMed ID: 24180679
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
[TBL] [Abstract][Full Text] [Related]
8. Comparison of anticoagulation and thrombolysis treatments in a rat model of superior sagittal sinus thrombosis.
Wang J; Ji X; Ling F; He X
Int J Neurosci; 2014 Jul; 124(7):532-41. PubMed ID: 24195615
[TBL] [Abstract][Full Text] [Related]
9. Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke.
Niessen F; Hilger T; Hoehn M; Hossmann KA
Stroke; 2003 Aug; 34(8):2019-24. PubMed ID: 12843350
[TBL] [Abstract][Full Text] [Related]
10. Cerebral venous thrombosis: combined intrathrombus rtPA and intravenous heparin.
Frey JL; Muro GJ; McDougall CG; Dean BL; Jahnke HK
Stroke; 1999 Mar; 30(3):489-94. PubMed ID: 10066841
[TBL] [Abstract][Full Text] [Related]
11. Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion.
Straub S; Junghans U; Jovanovic V; Wittsack HJ; Seitz RJ; Siebler M
Stroke; 2004 Mar; 35(3):705-9. PubMed ID: 14752128
[TBL] [Abstract][Full Text] [Related]
12. [Use of a combination of enoxaparin or unfractionated heparin and abciximab during percutaneous coronary interventions: a randomized pilot study].
Galeote G; Hussein M; Sobrino N; Calvo L; Sánchez-Recalde A; Sobrino JA
Rev Esp Cardiol; 2002 Dec; 55(12):1261-6. PubMed ID: 12459075
[TBL] [Abstract][Full Text] [Related]
13. Analysis of combined treatment of embolic stroke in rat with r-tPA and a GPIIb/IIIa inhibitor.
Ding G; Jiang Q; Zhang L; Zhang ZG; Li L; Knight RA; Ewing JR; Wang Y; Chopp M
J Cereb Blood Flow Metab; 2005 Jan; 25(1):87-97. PubMed ID: 15678115
[TBL] [Abstract][Full Text] [Related]
14. Absence of potentiation with murine antiplatelet GPIIb/IIIa antibody of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in a canine venous thrombosis model.
Spriggs D; Gold HK; Hashimoto Y; Van Houtte E; Vermylen J; Collen D
Thromb Haemost; 1989 Feb; 61(1):93-6. PubMed ID: 2501892
[TBL] [Abstract][Full Text] [Related]
15. Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis.
Wasay M; Bakshi R; Kojan S; Bobustuc G; Dubey N; Unwin DH
Stroke; 2001 Oct; 32(10):2310-7. PubMed ID: 11588319
[TBL] [Abstract][Full Text] [Related]
16. Radiological and histological changes following cerebral venous sinus thrombosis in a rat model.
Srivastava AK; Kalita J; Haris M; Gupta RK; Misra UK
Neurosci Res; 2009 Dec; 65(4):343-6. PubMed ID: 19715733
[TBL] [Abstract][Full Text] [Related]
17. Successful intra-arterial thrombolysis beyond the accepted 6-hour time window in two young patients.
Coster S; van Dijk LC; Treurniet FE; van Overhagen H; van Woerkom TC
J Neurol Sci; 2010 Jan; 288(1-2):182-5. PubMed ID: 19863970
[TBL] [Abstract][Full Text] [Related]
18. Glycoprotein IIb/IIIa receptor antagonist (2S)-2-[(2-Naphthyl-sulfonyl)amino]-3-[[2-([4-(4-piperidinyl)-2-[2-(4-piperidinyl)ethyl] butanoyl]amino)acetyl]amino]propanoic acid dihydrochloride (CRL42796), in combination with aspirin and/or enoxaparin, prevents coronary artery rethrombosis after successful thrombolytic treatment by recombinant tissue plasminogen activator.
Hong TT; Driscoll EM; White AJ; Sherigill A; Giboulot TA; Lucchesi BR
J Pharmacol Exp Ther; 2003 Aug; 306(2):616-23. PubMed ID: 12734394
[TBL] [Abstract][Full Text] [Related]
19. Good outcome in early pregnancy following direct thrombolysis for cerebral venous sinus thrombosis.
Weatherby SJ; Edwards NC; West R; Heafield MT
J Neurol; 2003 Nov; 250(11):1372-3. PubMed ID: 14648156
[No Abstract] [Full Text] [Related]
20. [Local thrombolysis of sinus thrombosis].
Soll NH; Vestergård K; Nepper-Rasmussen J
Ugeskr Laeger; 2009 Nov; 171(45):3284-5. PubMed ID: 19887060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
